Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Swisse Sleep (marketed as Swisse Ultiboost Sleep) is a multi-ingredient dietary supplement formulated to assist with natural, restful sleep and the relief of nervous tension. Produced by Swisse Wellness, the supplement contains a blend of botanical extracts and minerals, primarily featuring valerian root (*Valeriana officinalis*) and magnesium. Other herbal components often include hops, licorice, China root, and *Anemarrhena asphodeloides*. Valerian is traditionally recognized for its sedative properties, likely mediated through the modulation of GABAergic pathways, while magnesium serves as an essential mineral that supports muscle relaxation and nervous system function. As a nutraceutical product, it is intended for the management of occasional sleeplessness and mild insomnia symptoms rather than as a primary pharmaceutical intervention for chronic sleep disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Swisse Sleep.